Oncology program advancing with data expected in the fourth quarter 2025
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Seeking Alpha / 8 hours ago 2 Views
Seeking Alpha / 8 hours ago 2 Views
Oncology program advancing with data expected in the fourth quarter 2025
Comments